Director/PDMR Shareholding
1 August 2022 15:05 BST Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that on 29 July 2022 awards of AstraZeneca American Depositary Shares (ADSs) vested to Dr Aradhana Sarin, Executive Director and Chief Financial Officer. Each ADS represents one half of an Ordinary Share of $0.25 in the Company. In accordance with the Agreement and Plan of Merger between the Company and Alexion Pharmaceuticals, Inc. (Alexion), Dr Sarin's in-flight share awards granted by Alexion were converted to 2017 Incentive Plan. Following the